Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FABLE: Florensocatib in Bronchiectasis
NCT07577804Phase 3Not yet recruiting
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Nov 2026
- Primary completion
- Apr 2030
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of florensocatib in bronchiectasis, sponsored by Chiesi Farmaceutici S.p.A.. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
florensocatib
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT07577804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07577804.